SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-078766
Filing Date
2021-06-09
Accepted
2021-06-09 16:10:32
Documents
13
Period of Report
2021-06-09
Items
Item 2.06: Material Impairments

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2118507d2_8k.htm   iXBRL 8-K 27036
  Complete submission text file 0001104659-21-078766.txt   246240

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA elan-20210609.xsd EX-101.SCH 3899
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE elan-20210609_def.xml EX-101.DEF 27028
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE elan-20210609_lab.xml EX-101.LAB 37942
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elan-20210609_pre.xml EX-101.PRE 25640
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2118507d2_8k_htm.xml XML 5214
Mailing Address 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address 2500 INNOVATION WAY GREENFIELD IN 46140 877-352-6261
Elanco Animal Health Inc (Filer) CIK: 0001739104 (see all company filings)

IRS No.: 825497352 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38661 | Film No.: 211005242
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences